🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
50.78
-0.68 (-1.32%)
At close: Nov 20, 2026, 4:00 PM EST
52.48
+1.70 (3.35%)
After-hours: Nov 20, 2026, 7:38 PM EST

Cytokinetics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
203.43122.5294.86113.0265.58112.67
Short-Term Investments
926.59759.7981.16501.8717358.97
Cash & Short-Term Investments
1,130882.221,076614.82782.58471.64
Cash Growth
17.40%-18.01%75.01%-21.44%65.93%1.63%
Accounts Receivable
33.8917.7616.651.280.1556.82
Receivables
33.8917.7616.651.280.1556.82
Prepaid Expenses
22.4316.9915.2811.9412.467.22
Total Current Assets
1,187916.981,108628.05795.19535.67
Property, Plant & Equipment
147.69155.17140.97147.74163.19146.41
Long-Term Investments
458.63335.05145.0640.5346.71152.05
Other Long-Term Assets
31.3117.347.7189.697.19
Total Assets
1,8251,4251,402824.321,015841.32

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
25.9622.3420.3721.5125.6121.09
Accrued Expenses
90.8783.2855.3242.6444.134.37
Short-Term Debt
31.331.111.3---
Current Portion of Long-Term Debt
174.441.1811.5210.080.96-
Current Portion of Leases
21.3919.1118.9817.8912.8314.86
Current Unearned Revenue
1.651.6152.37---
Other Current Liabilities
7.843.839.8110.561.121.54
Total Current Liabilities
353.42202.45179.67102.6884.6271.86
Long-Term Debt
1,1001,239768.6607.37609.62142.84
Long-Term Leases
99.67107.97112.58120.43126.9112.23
Long-Term Unearned Revenue
579.56520.56462.19379.98300.5266.07
Other Long-Term Liabilities
13.213.7140.191.044.46
Total Liabilities
2,1462,0841,5371,2111,123597.46

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.140.120.120.10.090.08
Additional Paid-In Capital
3,7692,8262,5641,7261,4821,452
Retained Earnings
-4,082-3,487-2,702-2,112-1,586-1,208
Comprehensive Income & Other
-8.390.632.4-0.01-3.59-0.87
Shareholders' Equity
-321.17-659.63-135.37-386.32-107.9243.86
Total Liabilities & Equity
1,8251,4251,402824.321,015841.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,4271,439922.98755.77750.3269.93
Net Cash (Debt)
-296.84-556.62153.04-140.9532.28201.71
Net Cash Growth
-----84.00%-37.96%
Net Cash Per Share
-2.30-4.631.37-1.460.362.62
Filing Date Shares Outstanding
139.3123.16118.4110395.1684.86
Total Common Shares Outstanding
139.22122.94118.21101.6494.8384.8
Working Capital
833.73714.52928.27525.37710.57463.81
Book Value Per Share
-2.31-5.37-1.15-3.80-1.142.88
Tangible Book Value
-321.17-659.63-135.37-386.32-107.9243.86
Tangible Book Value Per Share
-2.31-5.37-1.15-3.80-1.142.88
Machinery
-35.3230.8228.1628.4527.48
Construction In Progress
-10.354.070.220.740.22
Leasehold Improvements
-80.266.8766.8765.9160.34
SEC Filings: 10-K · 10-Q